Boston's scientific's layoffs, annouced last summer, also had nothing to do with the exise tax, which it didn't mention:

Boston Scientific has faced weak markets for its key products -- heart stents and implantable heart defibrillators -- for several years as the number of procedures has dropped, partly because of a weak economy and heightened scrutiny over their use.

The medical device maker, which has been struggling since its 2006 acquisition of heart stent maker Guidant Corp, is expected to announce the additional layoffs within the next two months, according to a person close to the company.

Announcements

When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.

Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.